Epidemiology: Data from Cancer Registries

  • Maurizio Montella
  • Carlotta Buzzoni
  • Anna Crispo
Part of the Updates in Surgery book series (UPDATESSURG)


Recent advances in the cancer treatment and the resulting increase in patient survival have led to greater scientific interest in multiple primary malignancies (MPM). It is now recognized that longer survival combined with the administration of active but toxic therapeutic regimens has made patients more prone to develop a “second primary cancer,” as a consequence of therapy (e.g., thyroid cancer in lymphoma patients treated with radiotherapy) or of longer exposure to risk factors [1].


Cancer Survivor Cancer Registry Childhood Cancer Subsequent Tumor Subsequent Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Curtis RE, Freedman M, Ron E et al (eds) (2006) New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000, NCI, Bethesda pp 1–7Google Scholar
  2. 2.
    IARC/IACR (2004) International rules for multiple primary cancer. ICD-O, 3rd edn. International Agency for Research on Cancer, Lyon, Internal Report 2004/02Google Scholar
  3. 3.
    Crocetti E, Lecker S, Buiatti E, Storm HH (1996) Problems related to coding of multiple primary cancers. Eur J Cancer 32A:1366–1370PubMedCrossRefGoogle Scholar
  4. 4.
    National Cancer Institutes (2007) SEER program coding and staging manual. Released May 15, 2007. Available at (last access July 2008)Google Scholar
  5. 5.
    Banca Dati Airtum. Available at (last access July 2008)Google Scholar
  6. 6.
    EUROCARE website. Available at (last access July 2008).Google Scholar
  7. 7.
    Rosso S, De Angelis R, Ciccolallo L et al (2008) Survival with multiple tumors. Eur J Cancer (in press)Google Scholar
  8. 8.
    National Cancer Institute (2006) About SEER. NIH publication no. 05-4772. Available at (last access July 2008)Google Scholar
  9. 9.
    Mariotto AB, Yabroff KR, Feuer EJ et al (2006) Projecting the number of patients with colorectal carcinoma by phases of care in the US: 2000-2020. Cancer Causes Control 17(10):1215–1226PubMedCrossRefGoogle Scholar
  10. 10.
    Neglia JP, Friedman DL, Yasui Y et al (2001) Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 93(8):618–629PubMedCrossRefGoogle Scholar
  11. 11.
    Bhatia S (2005) What is the risk of second malignant neoplasms after childhood cancer? Nat Clin Pract Oncol 2(4): 182–183PubMedCrossRefGoogle Scholar
  12. 12.
    Boffetta P, Hashibe M, La Vecchia C et al (2006) The burden of cancer attributable to alcohol drinking. Int J Cancer 119(4): 884–887PubMedCrossRefGoogle Scholar
  13. 13.
    Vineis P, Alavanja M, Buffler P et al (2004) Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 96(2):99–106PubMedCrossRefGoogle Scholar
  14. 14.
    Aziz NM, Rowland JH (2003) Trends and advances in cancer survivorship research: challenge and opportunity. Semin Radiat Oncol 13(3):248–266PubMedCrossRefGoogle Scholar
  15. 15.
    Bellizzi KM, Rowland JH, Jeffery DD et al (2005) Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol 23(34):8884–8893PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • Maurizio Montella
    • 1
  • Carlotta Buzzoni
    • 2
  • Anna Crispo
    • 1
  1. 1.Epidemiology UnitINTNaplesItaly
  2. 2.AIRTUM and Epidemiology Clinical and Descriptive Unit CSPOFlorenceItaly

Personalised recommendations